Shengfeng Wang

Tenured Associate Professor
wangshengfeng@bjmu.edu.cn
Xueyuan Road 38, Haidian District, Beijing, China
Peking University

Personal profile

Wang Shengfeng, Ph.D., Tenured Associate Professor / Researcher, Doctoral Supervisor. He is a recipient of the National Young Talent Program, Peking University Boya Young Scholar, and serves as Assistant Dean of the School of Public Health, Peking University. Dr. Wang received his Ph.D. in Epidemiology and Biostatistics from the School of Public Health, Peking University in 2012, and subsequently joined the faculty. He worked as a visiting scholar at the Pritzker School of Medicine, University of Chicago from 2015 to 2017.

As a principal investigator, he has led 20 projects, including grants from the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Doctoral Program Foundation of the Ministry of Education, and the Key Project of Beijing Health Development Research Specialized Program. In the past five years, he has published over 150 papers in Chinese and English, with first/corresponding-author papers appearing in prestigious international journals such as Lancet HIV, JAMA Network Open, PLOS Medicine, Environmental Health Perspectives, and The American Journal of Gastroenterology.

Dr. Wang holds numerous academic leadership and committee positions, including: the Deputy Director of Diabetes Professional Committee, Chinese Medical Education Association; Health Education Methodology Branch, China Association of Health Promotion and Education; the Executive Committee Member of Rare Disease Professional Committee, Chinese Medical Association; the Member of Respiratory Disease Prevention and Control Committee, Chinese Preventive Medicine Association; Pharmacoepidemiology Professional Committee, Chinese Pharmaceutical Association; Public Health Ophthalmology Committee, Chinese Preventive Medicine Association; Youth Health Economics Branch, China Health Economics Association; the Technical Review Expert of Medical Devices, National Medical Products Administration; the Editorial Board Member of China Health Standard Management (Health Technology Assessment and Comprehensive Evaluation of Pharmaceuticals); the Standing Committee Member of Big Data Branch, Beijing Chronic Disease Prevention and Health Education Research Association; the Deputy Director of Ophthalmology Professional Committee, Beijing Chronic Disease Prevention and Health Education Research Association; He also serves on editorial boards as a Youth Editorial Board Member for Fundamental Research, and as a Corresponding/Youth Editorial Board Member for Chinese Journal of Epidemiology, Chinese Journal of Oncology, Chinese Journal of Pharmacoepidemiology, and Chinese Journal of Cancer Prevention and Treatment.

Dr. Wang is the Director of the Beijing Young University Teachers’ Innovative Teaching and Research Studio. His honors include: Yang Fuqing-Wang Yangyuan Academician Award for Excellence in Teaching (2025), Peking University Teaching Excellence Award (2024), Peking University Boya Young Scholar (2023), Peking University Health Science Center Inaugural Teaching Rising Star Award (2022), Peking University Zhongwai Medical Award (2022), First Prize, Beijing University Teacher Teaching Innovation Competition (2022), First Prize, National Blended Teaching Design Competition (2021), Peking University Zhengda Award (2020), First Prize, Beijing University Young Teacher Basic Teaching Skills Competition (2019).

Main research directions

Chronic Disease Epidemiology (with a focus on oncology)

Development and Application of Digital and Intelligent Technologies (with a focus on pharmaceuticals and rare diseases).

Representative scientific research projects

1. National Key Research and Development Program of China, Construction of a Panoramic Atlas of Pulmonary Thromboembolism and Research on Genetic-Environmental Interactions, Principal Investigator

2. National Key Research and Development Program of China, Health Economics Evaluation and Policy Translation of the Comprehensive Prevention and Treatment System for Pulmonary Thromboembolism, Principal Investigator

3. National Natural Science Foundation of China, Design and Empirical Research on the Multi-Security Mechanism for Rare Diseases Driven by Digital Intelligence, Principal Investigator

4. Key Project of Beijing Health Development Research Specialized Program, Strategies and Technologies for Active Monitoring of Vaccine Safety in Beijing Driven by Big Data, Principal Investigator

5. National Key Research and Development Program of China, Construction of Cohort and Data Platform for Research about Urinary Function of the Elderly Patients, Sub-investigator

6. Capital Health Development Research Project, Prostate Cancer Precision Screening and Health Economics Evaluation in Beijing, Co-principal

7. National Natural Science Foundation of China (General Program), Strategy and Empirical Research on Handling Time-dependent Variables in Adverse Drug Reaction Prediction Based on Dynamic Bayesian Networks and Transfer Learning, Principal Investigator

8. Science and Technology Project by State Grid Corporation (State Grid), Risk Assessment Technology and Prevention Strategy of Occupational Hazard Emergencies in Power Grid Corporation, Sub-investigator

9. National Key Research and Development Program of China, Data Collection Standards and Sharing Mechanism Based on Population Cancer Registry Data and Hospital Diagnostic Data, Task Leader

10. National Natural Science Foundation of China, A Methodology Study of Control Selection in Electronic Medical Records-based Safety Surveillance, Principal Investigator

10 representative papers

1. Ding Ranyi#, Wang Yutong#, Yu Yuelin#, Meng Xianglong, Gong Quanquan, Tang Yuchuan, Wang Jinhao, Mu Xianlin, Li Huiping, Zhou Huziwei, Wang Shengfeng*, Liu Ping*. Effectiveness of a Multifaceted Intervention (TEMP) for Prevention of Occupational Heat-Related Illness among Outdoor Workers in the Power Grid Industry: A Cluster Randomized Controlled Trial. Environ Health Perspect, 2025,133(1):17001. (数智化干预的整群随机对照试验，IF = 10.100)

2. Dong Xiaowu, Zhu Qingtian, Yuan Chenchen, Wang Yaodong, Ma Xiaojie, Shi Xiaolei, Chen Weiwei, Dong Zhao, Chen Lin, Shen Qinhao, Xu Hongwei, Ding Yanbing, Gong Weijuan, Xiao Weiming, Wang Shengfeng*, Li Weiqin*, Lu Guotao*. Associations of intra-pancreatic fat deposition with incident diseases of the exocrine and endocrine pancreas: A UK Biobank prospective cohort study. Am J Gastroenterol. 2024,119(6):1158-1166. (IF = 12.600)

3. Xu lu, He Bingjie, Sun Yexiang, Li Jun, Shen Peng, Hu Liming, Liu Guozhen, Wang Jinxi, Duan Liping*, Zhan Siyan*, Wang Shengfeng*. Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study. Clin Gastroenterol Hepatol, 2023, 21(13):3379-3386. (IF = 12.600)

4. Zheng Xuanqi#, Xu Lu#, Huang Jie, Zhang Chenggui, Yuan Wanqiong, Sun Chuiguo, Zhang Zhishan, Wei Chen, Wang Jinxi, Cummings Steven R, Xia Weibo, Wang Shengfeng*, Zhan Siyan*, Song Chunli*. Incidence and cost of vertebral fracture in urban China: A five-year population-based cohort study. Int J Surg. 2023, 109(7):1910-1918. (IF = 15.300)

5. Wen Qiaorui#, Liu Tanxin#, Yu Yuelin#, Zhang Yunjing, Yang Yingzi, Zheng Rongshou, Li Liming, Chen Ru*, Wang Shengfeng*. Self-Reported Primary Cooking Fuels Use and Risk of Chronic Digestive Diseases: A Prospective Cohort Study of 0.5 Million Chinese Adults. Environ Health Perspect. 2023, 131(4):47002. (IF = 11.305)

6. Zhou Huziwei#, Qiao Liying#, Zhang Yunjing, Kang Weiwei, Yan xue, Jiang Yuling, Ke Yalei, Rao Yingting, Liu Guozhen, Wang Mingyuan, Wang Hui, Xi Yunfeng*, Wang Shengfeng*. Association of Ethnicity, Sex, and Age With Cancer Diagnoses and Health Care Utilization Among Children in Inner Mongolia, China. JAMA Network Open. 2022, 5(9):e2231182. (IF = 13.360)

7. Chen Fangfang#, Cai Chang#, Wang Shengfeng#, Qin Qianqian, Jin Yichen , Li Dongmin, Ge Lin, Li Peilong, Cui Yan, Tang Houlin*, Lv Fan*.Trends in suicide mortality among people with HIV after diagnosis during 2012-18: a retrospective, national cohort study in China. Lancet HIV. 2022, 9(2):e102-e111. (IF = 16.070)

8. Sun Yixin#, Zhou Guoyu#, Feng Jingnan, Chen Lu, Liu Gguozhen, Wang Jinxin, Wang Qingliang, Yu Junyou, Yang Xiwang, Yang Zheng, Gao Pei*, Wang Shengfeng*, Zhan Siyan*. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study. Stroke and vascular neurology,2021, 6(4), 615–623. (IF = 9.893，入选北京市科协2023年首都前沿学术成果[脑科学领域])

9. Zhang Chenggui#, Feng Jingnan#, Wang Shengfeng#, Gao Pei#, Xu Lu, Zhu Junxiong, Jia Jialin, Liu Lili, Liu Guozhen, Wang Jinxi, Zhan Siyan*, Song Chunli*; Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLOS Medicine, 2020, 17(8):e1003180. (IF = 11.069)

10. Xu Lu#; Chen Lu#; Wang Shengfeng#; Feng Jingnan; Liu Lili; Liu Guozhen; Wang Jinxi; Zhan Siyan*; Gao Pei; Fan Dongsheng; Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study, Journal of Neurology, Neurosurgery, and Psychiatry, 2020, 91:520-525. (IF =10.283，入选中国2020年度重要医学进展)